Technical / White Paper
Recipharm already has experience in serialised production. From our UK facility in Manchester over 40 batches have been delivered from a fully validated line to the Turkish market since 2010.
Serialisation is a complex area and the requirements are likely to develop and change over time. It is not an area that can be ignored regardless of whether the drug being sold is a brand new high value molecule or a commodity generic.